# Niranjan Bose

> Science Advisor di Bill Gates: Managing Director Health & Life Sciences a Gates Ventures, architetto della strategia salute globale e Alzheimer

## Dati Essenziali

| Aspetto | Dettaglio |
|---------|-----------|
| **Nazionalita'** | IND-USA |
| **Titolo** | PhD |
| **Ruolo attuale** | Managing Director Health & Life Sciences, Gates Ventures |

---

## Formazione

| Periodo | Istituzione | Dettaglio |
|---------|-------------|-----------|
| **1992-1997** | [BITS Pilani](../university/bits-pilani.md) | B.Pharm (Pharmaceutical Sciences), MS Biological Sciences |
| **1998-2004** | [Dartmouth College](../university/dartmouth.md) | PhD Biochemistry (Geisel School of Medicine) |
| **-** | [Dartmouth Tuck](../university/dartmouth.md) | Business Bridge Diploma |
| **2011-2012** | University of Washington | Certificate Program in Clinical Trials |

**Attivita' a Dartmouth:**
- Program Coordinator, International House
- Graduate Student Council
- Cricket Club
- International Students Association

---

## Carriera e Ruoli

### Timeline Professionale

| Periodo | Ruolo | Organizzazione |
|---------|-------|----------------|
| **pre-2007** | Senior Consultant | [Strategic Decisions Group](../company/strategic-decisions-group.md) |
| **2007-2014** | Chief of Staff to President Global Health | [Gates Foundation](../foundation/gates-foundation.md) |
| **2007-2014** | Program Strategy, Enterics & Diarrheal Diseases | Gates Foundation |
| **2014-** | Managing Director Health & Life Sciences | [Gates Ventures](../company/gates-ventures.md) |
| **2020-2021** | Board Member, Interim CEO | [Global Health Labs](../foundation/global-health-labs.md) |
| **2020-** | Advisory Board, Executive Director (interim 2024-) | [ADDI](../foundation/addi.md) |

### Ruolo a Gates Ventures

| Aspetto | Dettaglio |
|---------|-----------|
| **Titolo** | Managing Director, Health & Life Sciences Strategy |
| **Funzione** | Science Advisor to Mr. Bill Gates |
| **Portfolio** | Investimenti filantropici in Global Health, Alzheimer, US Healthcare |

### Progetti Chiave

| Progetto | Descrizione | Status |
|----------|-------------|--------|
| **Exemplars in Global Health** | Ricerca su paesi con successi sanitari eccezionali | Incubato 7 anni, transizione a Gates Foundation 2025 |
| **AD Diagnostics Accelerator** | Acceleratore diagnostica Alzheimer | Attivo |
| **ADDI** | Piattaforma dati aperti Alzheimer | Executive Director (interim) |

---

## Rete di Connessioni

### Mappa delle Appartenenze

```
                   NIRANJAN BOSE
                         |
      +------------------+------------------+
      |                  |                  |
      v                  v                  v
   GATES              GATES              ADVISORY
   FOUNDATION        VENTURES            BOARDS
   (2007-2014)       (2014-)               |
      |                  |          +------+------+
      v                  v          v      v      v
   Global            Science      ADDI   GH    Last Mile
   Health            Advisor     (2020-) Labs   Health
   Program           to Gates           (2020-21)
```

### Board e Advisory Positions

| Organizzazione | Ruolo | Periodo |
|----------------|-------|---------|
| [ADDI](../foundation/addi.md) | Advisory Board → Executive Director (interim) | 2020- |
| [Global Health Labs](../foundation/global-health-labs.md) | Board, Interim CEO | 2020-2021 |
| Last Mile Health | Board of Advisors | - |
| Vellore Christian Medical College Foundation | Board | - |
| Institute for Health Metrics and Evaluation (IHME) | Affiliate Associate Professor | - |
| SV Health Investors | Independent | - |

### Network Professionale

| Nome | Connessione |
|------|-------------|
| [Bill Gates](bill-gates.md) | Science Advisor dal 2014 |
| [Michael Larson](michael-larson.md) | Collega ecosistema Gates |

---

## Aree di Expertise

### Salute Globale

| Area | Dettaglio |
|------|-----------|
| **Vaccini enterici** | Rotavirus, colera, E. coli, shigella |
| **Clinical development** | Portfolio management vaccini |
| **Exemplars research** | Paesi con successi sanitari (metodologia positive deviance) |

### Alzheimer e Demenza

| Iniziativa | Ruolo |
|------------|-------|
| AD Diagnostics Accelerator | Gates Ventures lead |
| Dementia Discovery Fund | Oversight |
| EQT Dementia Fund | Oversight |
| ADDI | Executive Director (interim) |

### Strategia e Consulenza

| Competenza | Dettaglio |
|------------|-----------|
| Strategy development | Pharma/biotech |
| Portfolio management | R&D investments |
| Company valuations | Life sciences |
| Revenue forecasting | Drug development |

---

## Citazioni

> "The pipeline for global health innovations is more robust than it's ever been. Scaling the fantastic pipeline innovations is truly the challenge we're going to face."
> — Niranjan Bose, Devex

---

## Connessioni PowerLink

### Organizzazioni

| Entita' | Connessione |
|---------|-------------|
| [Gates Ventures](../company/gates-ventures.md) | Managing Director 2014- |
| [Gates Foundation](../foundation/gates-foundation.md) | Chief of Staff Global Health 2007-2014 |
| [Dartmouth College](../university/dartmouth.md) | Alumni PhD Biochemistry |
| [BITS Pilani](../university/bits-pilani.md) | Alumni B.Pharm, MS |
| [ADDI](../foundation/addi.md) | Board, Executive Director (interim) 2020- |
| [Global Health Labs](../foundation/global-health-labs.md) | Board, Interim CEO 2020-2021 |
| [Strategic Decisions Group](../company/strategic-decisions-group.md) | Senior Consultant (pre-2007) |

### Persone

| Persona | Relazione |
|---------|-----------|
| [Bill Gates](bill-gates.md) | Science Advisor 2014- |

---

## Timeline

| Anno | Evento |
|------|--------|
| **1992** | Inizio studi BITS Pilani |
| **1997** | B.Pharm e MS, BITS Pilani |
| **1998** | Inizio PhD Dartmouth |
| **2004** | PhD Biochemistry, Dartmouth |
| **pre-2007** | Senior Consultant, Strategic Decisions Group |
| **2007** | Entra Gates Foundation, Global Health Program |
| **2011** | Certificate Clinical Trials, UW |
| **2014 ago** | Entra Gates Ventures come Managing Director |
| **2017** | Lancia Exemplars in Global Health |
| **2020** | Board ADDI, Board/Interim CEO Global Health Labs |
| **2021** | Fine ruolo Interim CEO GH Labs |
| **2024** | Executive Director (interim) ADDI |
| **2025** | Exemplars in Global Health transizione a Gates Foundation |

---

## Fonti

### Profili Ufficiali
- [Gates Ventures - Niranjan Bose](https://theorg.com/org/gates-notes/org-chart/niranjan-bose)
- [SV Health Investors](https://svhealthinvestors.com/people/niranjan-bose)
- [USC Schaeffer](https://schaeffer.usc.edu/people/niranjan-bose/)

### Interviste e Articoli
- [Gates Foundation - Exemplars Q&A](https://www.gatesfoundation.org/ideas/articles/exemplars-global-health-niranjan-bose)
- [Dartmouth Alumni Profile](https://graduate.dartmouth.edu/news/2017/04/alumni-profiles-niranjan-bose-04-phd-biochemistry-mcb)
- [Devex - Health Innovation Pipeline](https://www.devex.com/news/health-innovation-pipeline-more-robust-than-ever-says-gates-ventures-108558)

### Organizzazioni
- [ADDI Board](https://www.alzheimersdata.org/about/board-of-directors)
- [Exemplars in Global Health](https://www.exemplars.health/)

---

*Ultimo aggiornamento: Febbraio 2025*
